Research Output per year
Personal profile
Research Interests
Internal Medicine
External positions
Fingerprint Dive into the research topics where Kavitha Saravu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 74 Similar Profiles
India
Medicine & Life Sciences
Tertiary Healthcare
Medicine & Life Sciences
Vivax Malaria
Medicine & Life Sciences
Tertiary Care Centers
Medicine & Life Sciences
Melioidosis
Medicine & Life Sciences
Primaquine
Medicine & Life Sciences
Plasmodium vivax
Medicine & Life Sciences
Cohort Studies
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2002 2019
Adverse effects of fluoroquinolones: A retrospective cohort study in a South Indian tertiary healthcare facility
Mathews, B., Thalody, A. A., Miraj, S. S., Kunhikatta, V., Rao, M. & Saravu, K., 01-09-2019, In : Antibiotics. 8, 3, 104.Research output: Contribution to journal › Article
Open Access
Fluoroquinolones
Tertiary Healthcare
Drug-Related Side Effects and Adverse Reactions
Cohort Studies
Retrospective Studies
Characterization of platelet count and platelet indices and their potential role to predict severity in malaria
Gupta, P., Guddattu, V. & Saravu, K., 17-02-2019, In : Pathogens and Global Health. 113, 2, p. 86-93 8 p.Research output: Contribution to journal › Article
Platelet Count
Malaria
Blood Platelets
Thrombocytopenia
Sensitivity and Specificity
Diagnosing active tuberculosis in people living with HIV: an ongoing challenge
MacLean, E., Saravu, K. & Pai, M., 01-01-2019, In : Current Opinion in HIV and AIDS. 14, 1, p. 46-54 9 p.Research output: Contribution to journal › Article
Tuberculosis
HIV
Pharmaceutical Preparations
Routine Diagnostic Tests
Comorbidity
Drug-resistant tuberculosis: Progress towards shorter and safer regimens
Saravu, K. & Pai, M., 01-09-2019, In : Lung India. 36, 5, p. 373-375 3 p.Research output: Contribution to journal › Editorial
Open Access
Opportunistic infection at the start of antiretroviral therapy and baseline CD4 + count less than 50 cells/mm 3 are associated with poor immunological recovery
Tilak, A., Shenoy, S., Varma, M., Kamath, A., Tripathy, A., Sori, R. & Saravu, K., 01-01-2019, In : Journal of Basic and Clinical Physiology and Pharmacology. 30, 2, p. 163-171 9 p.Research output: Contribution to journal › Article
Opportunistic Infections
CD4 Lymphocyte Count
Tertiary Healthcare
Therapeutics
Tertiary Care Centers
Activities 2019 2019
- 1 Invited talk
3rd Manipal International Infectious Diseases Conference
Kavitha Saravu (Speaker)10-08-2019
Activity: Talk or presentation types › Invited talk